Raymond James Financial’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.8K Sell
300
-59,374
-99% -$950K ﹤0.01% 6100
2025
Q1
$1.02M Buy
59,674
+39,292
+193% +$672K ﹤0.01% 3462
2024
Q4
$505K Buy
+20,382
New +$505K ﹤0.01% 3881